Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Sir Chris Hoy has revealed he suffered a broken back as a result of his terminal cancer and was told by doctors he could not ...

Advanced prostate cancer can spread to your bones ... leaving people vulnerable to fractures from a fall or other accident. These fractures can cause pain directly, but metastatic cancer can ...

Efficacy of 177Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC: VISION secondary analysis. Safety profile of lutetium-177 in patients with impaired renal function: A retrospective ...

Olympic cyclist Sir Chris Hoy shared a devastating consequence of his terminal cancer diagnosis after it caused a fracture in the athlete's back. Six-time Olympic gold medallist Sir Chris was ...

Compression fractures of the spine can be mistaken for bone metastases in men with prostate cancer. Patients with bone metastases and/or benign compression fractures often present with back pain.

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).